Description
This test includes 9 markers including the Viral Capsid Antigen (VCA), Early Antigen (EA), and the Epstein-Barr nuclear antigen (anti-EBNA) antibodies.
Test technique: The Immunoarray, also known as microarray, is an advanced serological method for detecting antibodies in biological samples. Similar to the SeraSpot MicroArray, the Immunoarray enables simultaneous analysis of a variety of antibodies against specific antigens. By using nanoliter amounts of samples, antigens can be immobilized on microarrays, enabling precise and highly sensitive analysis. This technology provides efficient and comprehensive characterization of the patient’s immune response to infections such as EBV and contributes to more accurate diagnosis and treatment.